Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naive Patients With Type 2 Diabetes: A 26-week, randomized, controlled, multinational, treat-to-target trial: The BEGIN LOW VOLUME trial

✍ Scribed by Gough, S. C. L.; Bhargava, A.; Jain, R.; Mersebach, H.; Rasmussen, S.; Bergenstal, R. M.

• Book ID: 121283166
• Publisher: American Diabetes Association
• Year: 2013
• Tongue: English
• Weight: 443 KB
• Volume: 36
• Category: Article
• ISSN: 0149-5992
• DOI: 10.2337/dc12-2329